← Back

Aerospace Cf

Beijing Aerospace Changfeng Co., Ltd. operates in China across medical equipment, military electronics, and public security. It provides public safety integration and related software development services. The company also produces and sells infrared detectors and related products, modular integrated power supplies, and UPS/EPS power supply products, as well as manufactures and sells medical devices and offers medical engineering services. Founded in 1985, it is based in Beijing, China.

Price · split & dividend adjusted
News & notes moving 600855.CG
600855.CG3

Aerospace Changfeng's 2026 interim report shows net loss of 52.1894 million yuan, narrowing year-on-year

Aerospace Changfeng released its 2026 interim report. The company's total operating revenue was 257 million yuan, and net profit attributable to the parent was negative 52.1894 million yuan, a loss reduction of 3.4016 million yuan compared with the same period last year. Net cash flow from operating activities was negative 126 million yuan, an increase of 8.2533 million yuan year-on-year. The asset-liability ratio was 52.46%, down 1.98 percentage points from the same period last year. Gross margin was 24.77%, return on equity was negative 3.77%, and diluted earnings per share was negative 0.11 yuan. The number of shareholders was 76,300, and the top ten shareholders held 46.56% of the total share capital.
Jiemian·19dRead more →
600855.CG

Aerospace Changfeng expects first-half 2026 loss to widen to 58–62 million yuan

Aerospace Changfeng issued an announcement, expecting a first-half 2026 loss of 58 million to 62 million yuan, an increase in loss of 2.41 million to 6.41 million yuan compared with the same period last year. The company expects a net loss attributable to the parent after deducting non-recurring items of 67.02 million to 71.02 million yuan. The main reasons for the expected loss are a short-term decline in settlement of the military electronics power supply business due to product delivery delays, unimproved profitability in the infrared optoelectronics business as demand slows, and delays in market expansion caused by the postponed registration and certification of high-end medical equipment ECMO products. In the first quarter of 2026, the company achieved revenue of 77.77 million yuan, with a net loss attributable to the parent of 37.27 million yuan.
财中社·68dRead more →